AccScience Publishing / BH / Online First / DOI: 10.36922/BH026270036
Cite this article
6
Download
66
Views
Related Info Links
More by Authors Links
Journal Browser
Volume | Year
Issue
Search
News and Announcements
View All
PERSPECTIVE ARTICLE

Post-myocardial infarction care in remote Greece: When geography is a determinant of cardiovascular outcomes—The example of the Prespes region

Aliki Iliadou1,2*
Show Less
1 Laboratory of Biological Chemistry, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece
2 Prespes Rural Medical Center, Prespes, Greece
Brain & Heart, 026270036 https://doi.org/10.36922/BH026270036
Received: 2 July 2026 | Revised: 28 July 2026 | Accepted: 10 August 2026 | Published online: 26 August 2026
© 2026 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Abstract

Survival after myocardial infarction depends not only on reperfusion but on continuity of follow-up, medication adherence, rehabilitation and psychosocial support. In remote regions, geography disrupts each stage of this pathway. Using Prespes in northwestern Greece as an illustrative case, this perspective examines how long travel distances, absence of local percutaneous coronary intervention capability, successive transfers, limited specialist access and weak continuity of care affect acute and long-term outcomes. Existing local practices, including informal ECG sharing, telemedicine infrastructure and mobile health services, are described, highlighting their limited integration into routine care. A tiered implementation framework is proposed, distinguishing measures feasible with current resources, interventions requiring regional coordination and reforms dependent on national policy. Priorities include formal STEMI networks, simplified clinical pathways, protected early follow-up, telecardiology, supported use of patient-owned devices, specialist outreach, treatment simplification and improved access to rehabilitation. The objective is equitable evidence-based cardiovascular care regardless of place of residence.

Keywords
Myocardial infarction
Rural area
Rural cardiology
Medication adherence
Healthcare
Public health
Greek healthcare
STEMI networks
Funding
None.
Conflict of interest
The author declares no competing interests.
References
  1. Main Page ELSTAT - ELSTAT. Accessed June 28, 2026. https://www.statistics.gr/en/home/
  2. Andrikopoulos G, Pipilis A, Goudevenos J, et al. Epidemiological characteristics, management and early outcome of acute myocardial infarction in Greece: the HELlenic Infarction Observation Study. Hellenic J Cardiol. 2007;48(6):325-334.
  3. Kanakakis J, Ntalianis A, Papaioannou G, Hourdaki S, Parharidis G. Stent for Life Initiative – the Greek experience. EuroIntervention. 2012;8(P):P116-P120. doi: 10.4244/EIJV8SPA20
  4. Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2018;39(2):119-177. doi: 10.1093/eurheartj/ehx393
  5. Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J. 2023;44(38):3720-3826. doi: 10.1093/eurheartj/ehad191
  6. Stopyra JP, Snavely AC, Ashburn NP, et al. Rural EMS STEMI Patients – Why the Delay to PCI? Prehospital Emerg Care. 2024;28(7):947-954. doi: 10.1080/10903127.2024.2305967
  7. Dauerman HL, Bates ER, Kontos MC, et al. Nationwide Analysis of Patients With ST-Segment–Elevation Myocardial Infarction Transferred for Primary Percutaneous Intervention: Findings From the American Heart Association Mission: Lifeline Program. Circ Cardiovasc Interv. 2015;8(5):e002450. doi: 10.1161/CIRCINTERVENTIONS.114.002450
  8. Sigmundsson TS, Arnarson D, Rafnsson A, Magnússon V, Gunnarsson GT, Thorgeirsson G. Flutningstími og gæði meðferðar hjá sjúklingum með ST-hækkunar-hjartadrep á landsbyggðinni – fáir ná í kransæðavíkkun innan 120 mínútna [Transport and treatment of patients with STEMI in rural Iceland--Only a few patients receive PPCI within 120 minutes]. Laeknabladid. 2016;102(1):11-17. [In Icelandic] doi: 10.17992/lbl.2016.01.59
  9. Bhatia K, Qamar A, Hendrickson M, Arora S, Gupta MD. Reply. JACC Asia. 2023;3(3):535. doi: 10.1016/j.jacasi.2023.05.006
  10. Schoenborn S, Steratore AF, Hoffman A, Marshall TC, Shaver EB, Kiefer CS. Managing STEMIs without a Catheterization Lab: A Simulated Scenario to Improve Emergency Clinician Recognition and Execution of Thrombolysis in the Setting of Rural STEMI Management. J Educ Teach Emerg Med. 2024;9(2):S55-S77. doi: 10.21980/J8K933
  11. Candiello A, Alexander T, Delport R, et al. How to set up regional STEMI networks: a “Stent - Save a life!” initiative. EuroIntervention. 2022;17(16):1313-1317. doi: 10.4244/eij-d-21-00694
  12. Halvorsen S. STEMI treatment in areas remote from primary PCI centres. EuroIntervention. 2012;8(P):P44-P50. doi: 10.4244/EIJV8SPA8
  13. Hayıroğlu Mİ. Telemedicine: Current Concepts and Future Perceptions. Anatol J Cardiol. 2019. doi: 10.14744/AnatolJCardiol.2019.12525
  14. Hoedemaker NPG, de Winter RJ, Kommer GJ, et al. Expansion of off-site percutaneous coronary intervention centres significantly reduces ambulance driving time to primary PCI in the Netherlands. Neth Heart J. 2020;28(11):584-594. doi: 10.1007/s12471-020-01466-2
  15. Shanmugasegaram S, Oh P, Reid RD, McCumber T, Grace SL. Cardiac rehabilitation barriers by rurality and socioeconomic status: a cross-sectional study. Int J Equity Health. 2013;12(1):72. doi: 10.1186/1475-9276-12-72
  16. Anastasiadis F, Antoniadis D, Chountis D, et al. Long-term risk, clinical management, and healthcare resource utilization of stable patients with coronary artery disease and post-myocardial infarction in Greece - TIGREECE study. Hell J Cardiol. 2023;72:24-33. doi: 10.1016/j.hjc.2023.01.007
  17. Faridi KF, Peterson ED, McCoy LA, Thomas L, Enriquez J, Wang TY. Timing of First Postdischarge Follow-up and Medication Adherence After Acute Myocardial Infarction. JAMA Cardiol. 2016;1(2):147-155. doi: 10.1001/jamacardio.2016.0001
  18. Smith SC, Benjamin EJ, Bonow RO, et al. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update. JACC. 2011;58(23):2432-2446. doi: 10.1016/j.jacc.2011.10.824
  19. Wang H, Zhao T, Wei X, Lu H, Lin X. The prevalence of 30-day readmission after acute myocardial infarction: A systematic review and meta-analysis. Clin Cardiol. 2019;42(10):889-898. doi: 10.1002/clc.23238
  20. Hanssen TA, Nordrehaug JE, Eide GE, Hanestad BR. Improving outcomes after myocardial infarction: a randomized controlled trial evaluating effects of a telephone follow-up intervention. Eur J Cardiovasc Prev Rehabil. 2007;14(3):429-437. doi: 10.1097/HJR.0b013e32801da123
  21. Mathews R, Peterson ED, Honeycutt E, et al. Early Medication Nonadherence After Acute Myocardial Infarction: Insights into Actionable Opportunities From the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) Study. Circ Cardiovasc Qual Outcomes. 2015;8(4):347-356. doi: 10.1161/CIRCOUTCOMES.114.001223
  22. Gaziano T, Castellano JM, Dymond A, et al. Cost-effectiveness of the CV-polypill strategy versus standard care for secondary cardiovascular prevention in Spain: an analysis based on the SECURE trial. Lancet Reg Health Eur. 2025;55:101348. doi: 10.1016/j.lanepe.2025.101348
  23. Peritogiannis V, Samakouri M, Vgontzas A. Mobile Mental Health Units in rural Greece: successful and cost-effective model. BJPsych Int. 2025:1-3. doi: 10.1192/bji.2025.10052
  24. Frederix I, Caiani EG, Dendale P, et al. ESC e-Cardiology Working Group Position Paper: Overcoming challenges in digital health implementation in cardiovascular medicine. Eur J Prev Cardiolog. 2019;26(11):1166-1177. doi: 10.1177/2047487319832394
  25. Gallegos-Rejas VM, Rawstorn JC, Gallagher R, Mahoney R, Thomas EE. Key features in telehealth-delivered cardiac rehabilitation required to optimize cardiovascular health in coronary heart disease: a systematic review and realist synthesis. Eur Heart J Digit Health. 2024;5(3):208-218. doi: 10.1093/ehjdh/ztad080
  26. Zorina O, Fatkulina N, Saduyeva F, Omarkulov B, Serikova S. Patient Adherence to Therapy After Myocardial Infarction: A Scoping Review. PPA. 2022;16:1613-1622. doi: 10.2147/PPA.S356653
  27. Karanikas H, Tsoukas V, Drakopoulos D, Koukoulas G, Katsapi A, Rizos F. Assessing Greek National Telemedicine Network. In: eTELEMED 2024 : The Sixteenth International Conference on eHealth, Telemedicine, and Social Medicine. Barcelona, Spain; 2024. Accessed July 24, 2026. https://personales.upv.es/thinkmind/dl/conferences/etelemed/etelemed_2024/etelemed_2024_1_100_40033.pdf
  28. Şaylık F. Digital Health Interventions in Patient Management Following Acute Coronary Syndrome: A Meta-Analysis of the Literature. Anatol J Cardiol. 2023;27(1):2-9. doi: 10.14744/AnatolJCardiol.2022.2254
  29. Sîngeap MS, Corneanu LE, Prodaniuc A, Șova IA, Coșovanu EO, Petriș OR. Diagnostic Accuracy of Wearable ECG Devices for Atrial Fibrillation and ST-Segment Changes: A Systematic Review. Diagnostics. 2025;15(24):3162. doi: 10.3390/diagnostics15243162
  30. US Food and Drug Administration. Letter to Samsung Electronics Co., Ltd regarding de novo classification request for sleep apnea feature. DEN230041. 2024. Accessed July 21, 2026. https://www.accessdata.fda.gov/cdrh_docs/pdf23/DEN230041.pdf
  31. Brew B, Faux SG, Blanchard E. Effectiveness of a Smartwatch App in Detecting Induced Falls: Observational Study. JMIR Form Res. 2022;6(3):e30121. doi: 10.2196/30121
  32. Hayıroğlu Mİ, Çınar T, Cilli Hayıroğlu S, Şaylık F, Uzun M, Tekkeşin Aİ. The role of smart devices and mobile application on the change in peak VO2 in patients with high cardiovascular risk: a sub-study of the LIGHT randomised clinical trial. Acta Cardiol. 2023;78(9):1000-1005. doi: 10.1080/00015385.2023.2223005
  33. Hayıroğlu Mİ, Çinier G, Yüksel G, et al. Effect of a mobile application and smart devices on heart rate variability in diabetic patients with high cardiovascular risk: A sub-study of the LIGHT randomized clinical trial. Pol Heart J. 2021;79(11):1239-1244. doi: 10.33963/KP.a2021.0112
  34. Cohen JB, Byfield RL, Hardy ST, et al. Cuffless Devices for the Measurement of Blood Pressure: A Scientific Statement From the American Heart Association. Hypertension. 2026;83(3). doi: 10.1161/HYP.0000000000000254
  35. Hellenic Republic. Mobile Health Units-Primary Health Care. 2025. Accessed June 26, 2026. https://www.government.gov.gr/
  36. Hellenic National Public Health Organization (EODY). Mobile Health Units. Hellenic National Public Health Organization (EODY). 2025. Accessed May 15, 2026. https://www.eody.gov.gr/el/en/symvanta-dimosias-ygeias/kinites-omades-ygeias-komy
  37. Mobile Medical Units: Free State-of-the-Αrt Care for the Rest of Greece - Stavros Niarchos Foundation. Accessed June 26, 2026. https://www.snf.org/en/news-stories/stories/mobile-medical-units-free-state-of-the-art-care-for-the-rest-of-greece/
  38. Remote Area Medical - SNF Global Health Initiative. Accessed June 26, 2026. https://www.snfghi.org/en/pillars/training-knowledge-exchange-and-partnerships/remote-area-medical/
Share
Back to top
Brain & Heart, Electronic ISSN: 2972-4139 Published by AccScience Publishing